Bio Techne earnings were $158.1M for the trailing 12 months ending Dec 31, 2024, with -29.1% growth year over year. The latest TECH earnings report on Dec 31, 2024 announced Q4 2024 earnings of $34.9M, up 3.8% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, TECH reported annual earnings of $168.1M, with -41.1% growth. The next TECH earnings date is Apr 29, 2025.
TECH past earnings growth
How has TECH's earnings growth performed historically?
On TECH's earnings call on Invalid Date, Bio Techne (NASDAQ: TECH) reported Q4 2024 earnings per share (EPS) of $0.22, up 29.41% year over year. Total TECH earnings for the quarter were $34.89 million. In the same quarter last year, Bio Techne's earnings per share (EPS) was $0.17.
The next TECH earnings call is Invalid Date. Add TECH to your watchlist to be reminded of Bio Techne's next earnings date.
What was TECH's earnings growth in the past year?
As of Bio Techne's earnings date in Invalid Date, Bio Techne's earnings has grown -29.08% year over year. This is 40.76 percentage points lower than the US Biotechnology industry earnings growth rate of 11.68%. TECH earnings in the past year totalled $158.14 million.
Is Bio Techne profitable or losing money?
As of the last Bio Techne earnings report, Bio Techne is currently profitable. Bio Techne's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $158.14 million, a 29.45% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.